Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
- 1 June 2004
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 84 (6), 766-777
- https://doi.org/10.1038/labinvest.3700094
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liverArchiv für die gesamte Virusforschung, 2004
- CSRP2, TIMP‐1, and SM22α promoter fragments direct hepatic stellate cell‐specific transgene expression in vitro, but not in vivoLiver International, 2004
- Inhibitory effect of a soluble transforming growth factor β type II receptor on the activation of rat hepatic stellate cells in primary cultureJournal of Hepatology, 2003
- PDGF and signal transduction in hepatic stellate cellsFrontiers in Bioscience-Landmark, 2002
- Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblastsHepatology, 2001
- Involvement of phosphatidylinositol 3‐kinase in the activation of extracellular signal‐regulated kinase by PDGF in hepatic stellate cellsFEBS Letters, 1995
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.Journal of Histochemistry & Cytochemistry, 1985
- Patterns of Amino Acids near Signal‐Sequence Cleavage SitesEuropean Journal of Biochemistry, 1983